Assessment of volume of distribution (VD) and half-life (T1/2) values during glomerular filtration rate (GFR) investigations is a useful quality control check. The aim of this study was to derive reference data for VD and T1/2 and also to provide reference data for GFR fro studies performed using 99mTcdiethylenetriaminepentaacetic acid.
Abstract
Background and aim Assessment of volume of distribution (V D ) and half-life (T ½ ) values during glomerular filtration rate (GFR) investigations is a useful quality control check. The aim of this study was to derive reference data for V D and T ½ and also to provide reference data for GFR from studies performed using 99m Tc-diethylenetriaminepentaacetic acid ( 99m Tc-DTPA).
Methods This was a retrospective study of 126 healthy potential kidney donors (age range 18-59 years). GFR was evaluated from 99m Tc-DTPA plasma clearance using the 2004 British
Nuclear Medicine Society guidelines. The association between V D and body surface area (BSA) was assessed. T ½ was correlated with age and with GFR. The correlation between Brochner-Mortensen-corrected GFR (BM-GFR Corr ) and age was evaluated.
Results Uncorrected V D (L) was ( 
Introduction
Glomerular filtration rate (GFR) is a standard measure of renal function. Although measuring plasma inulin clearance remains the gold standard for determining GFR, this technique is rarely used because it is time-consuming and difficult to perform [1, 2] . An estimate of GFR can be obtained by measuring creatinine clearance; however, this technique is inaccurate, especially in cases of poor renal function [3, 4] . Measurement of GFR using Nuclear Medicine techniques is considered a suitable alternative with clearance of 51 Cr-ethylenediaminetetraacetic acid ( 51 Cr-EDTA) having been shown to be similar to that of inulin [5, 6] . 99m Tc-diethylenetriaminepentaacetic acid ( 99m Tc-DTPA) is considered an acceptable alternative to 51 Cr-EDTA [1, 2] . It has the advantages of being inexpensive, widely available and the radiation dose to the patient is low. It is also suitable for gamma camera imaging, allowing simultaneous acquisition of a renogram for calculation of differential renal function. Clearance of 99m Tc-DTPA has been shown to correlate well with 51 Cr-EDTA clearance [7] .
In 2004 the British Nuclear Medicine Society (BNMS) published guidelines for the measurement of GFR [2] . The authors recommended measuring the plasma clearance of either 51 Cr-EDTA or 99m Tc-DTPA using the slope-intercept method with Brochner-Mortensen correction [2, 8] . In the clinical context this method provides a good compromise between accuracy and simplicity.
Nevertheless, careful attention to technique is warranted since methodological errors can be introduced at a number of stages [9] . These include, amongst others, errors in height or weight measurement, drawing up and injection of the patient dose, preparation or measurement of the standard, and preparation or measurement of the plasma samples.
The slope-intercept method does, however, offer a number of opportunities for quality control of the procedure [2] . Two parameters obtained during the calculation of GFR using the slopeintercept method are the volume of distribution (V D ) and the half-life (T ½ ) of the injected radiopharmaceutical [8] . While being of limited value for predicting the GFR in isolation, these values can be valuable to check for underlying methodological errors [2, 10, 11] . Using V D and T ½ for this purpose requires clearly defined reference ranges for each of these parameters. The BNMS guidelines provide a reference range for the uncorrected V D (L) as being linearly related to body surface area (BSA) (m 2 ) by the equation [2] :
This range for V D was obtained using 51 Cr-EDTA. It applies to an uncorrected value for V D , calculated using the formula:
where A is the administered activity and C the intercept at zero time obtained by back extrapolation of the terminal exponential of the curve of activity per unit volume versus time [12, Personal communication: G. Blake, King's College London, UK].
The Medical Physics Department of University Hospital Southampton NHS Foundation Trust, UK, found the corrected V D for 99m Tc-DTPA to be related to BSA by the equation [13] :
The values for V D were calculated using the equation:
where BM-GFR is the Brochner-Mortensen-corrected GFR [8] and k is the slope of the terminal exponential.
Equation 2 leads to an overestimation of the volume of distribution as it takes into account only the terminal exponential of the plasma clearance curve after mixing has taken place between the vascular and extravascular compartments [12] . The degree of overestimation is similar to that found when calculating GFR by the slope-intercept method without Brochner-Mortensen correction. The corrected volume of distribution, V D (corrected) (equation 4), although still an approximation since it assumes k is the terminal exponential, tries to correct for the overestimation.
A technique of measuring extracellular fluid volume (ECV) using a combination of the slope-only and slope intercept methods has been described and validated [14, 15] . Using this technique, reference data for ECV have recently been described by Peters et al in a large multi-centre study in the UK [16] .
In the BNMS guidelines T ½ is described as being "typically in the range" of 100-120 min in adults [2] . However, to the authors' knowledge no data has been published supporting the use of the above or other reference ranges for V D and T ½ . Specifically, there is a lack of published data for normal values of V D and T ½ that have been determined using 99m Tc-DTPA [17] .
Reference data for GFR have been well-defined by Granerus [18] , Hamilton et al [19] , Grewal and Blake [20] , as well as by Peters et al [16] . Although previous studies have shown only a small difference in GFR values obtained using 51 Cr-EDTA and 99m Tc-DTPA [21, 22] , there are no published reference ranges for GFR using 99m Tc-DTPA.
The aim of this study was to determine reference values for V D and T ½ from GFR studies using 99m Tc-DTPA in a healthy population. In addition, reference data for GFR using 99m Tc-DTPA have been defined for the study population.
Methods

Patient population:
This retrospective study included the GFR studies of all potential kidney donors referred to the 
Measurement of GFR, V D and T ½ :
All GFR studies were performed based on the protocol described in the BNMS guidelines [2] .
The subjects' heights and weights were recorded and the BSA calculated using the Haycock formula [25] . 99m Tc-DTPA (TechneScan® DTPA, Covidien) was injected intravenously. Labelling efficiency was greater than 90% in all cases. The injection site was imaged to exclude extravasation. The dose was approximately 40 MBq when only the GFR study was performed on that visit, and about 400 MBq when the GFR study was combined with a renogram. The patient and standard doses were accurately calibrated by weighing the syringes pre-and postinjection on a Precisa 620 C balance, without flushing the syringes or removing the needles.
Three 8 ml venous blood samples were drawn from the contralateral arm at 2, 3 and 4 hours respectively. The exact time of injection and the time of drawing each sample were recorded to the nearest minute. Samples were centrifuged immediately after being drawn. A standard was prepared by withdrawing a similar dose of 99m Tc-DTPA from the same kit and adding it to a halffilled 100 ml flask, which was subsequently filled to the 100 ml mark with distilled water and mixed. Two millilitres of this solution was pipetted into a second 100 ml flask that was filled and mixed in a similar manner. The dilution volume of the standard was thus equivalent to 5 litres.
Duplicate 1 ml aliquots of plasma samples and standard were pipetted into counting tubes.
Background counts were recorded, followed by the counting of each sample in a Picker NaI(Tl) well counter. All samples were counted sequentially in one sitting. Linearity of the well counter was checked routinely and was acceptable, specifically at high count rates.
The GFR was calculated using the slope-intercept method as described in the 2004 BNMS guidelines [2] . The natural logarithm of the plasma 99m Tc-DTPA concentrations were plotted against time. Linear regression analysis was used to determine the half-life (T ½ ) and V D (uncorrected). The slope-intercept GFR (SI-GFR) was calculated using the equation [2] :
The SI-GFR was then corrected for body surface area:
Subsequently, the mean Brochner-Mortensen (BM) equation was applied to correct for the missing area under the curve from the fast exponential [2] :
The coefficients used in this equation are an average of those in the adult [8] and paediatric equations [26] .
The absolute GFR was calculated by reversing the BSA correction:
For each GFR study the uncorrected V D was calculated using equation 2 and the corrected V D was calculated using equation 4.
Using the methodology previously described [14] [15] [16] , ECV-BSA (extracellular volume corrected to a BSA of 1.73 m 2 ) was calculated for each individual. Correction for BSA was reversed by multiplication of ECV-BSA with BSA/1.73m 2 to give ECV [16] .
Defining reference ranges:
Values for V D , both uncorrected and corrected, were plotted against BSA. Using linear regression analysis the correlation was determined between V D and BSA. Variability was defined by calculating the standard error of the estimate of the regression analysis. This gives the standard deviation of estimating V D from BSA. In this report the 95% confidence limits, or two standard deviations, are expressed as a percentage relative to the mean V D value. These results were compared to the accepted reference ranges described earlier (equations 1 and 3) [2, 13] and to the ECV-BSA data described by Peters et al [16] .
In order to define reference data for T ½ , the correlations of T ½ and age as well as T ½ and 1/BM-GFR Corr were determined . Similarly, the association between BM-GFR Corr and age was investigated using linear regression. Variability for these parameters was also described by the relative two standard deviation, expressed as a percentage. The results of the BM-GFR Corr vs.
age correlation were compared to 51 Cr-EDTA reference ranges described by Granerus [18] ,
Hamilton [19] and Grewal and Blake [20] and to the mean values for GFR described by Peters et al [16] .
Deviations from BNMS guidelines
The protocol used in this study deviated from the BNMS guidelines in two aspects and steps were taken to assess their impact on the calculated GFR and V D . Firstly, in 70 of the 126 studies, low counts were recorded for some of the samples. The BNMS guidelines state that, where practical, a minimum of 10 000 counts should be obtained from each sample in order to reduce statistical error [2] . The effect of this factor on the accuracy of the GFR and V D was assessed by introducing simulated random error into the counts that were obtained from all samples in all 126 studies. This was repeated 10 times and GFR and V D were calculated in each instance. From this data, systematic, random and total error was estimated.
A second deviation from the BNMS guidelines was that no correction was performed for decay of 99m Tc during the counting process. In order to quantify the error introduced by not correcting for radioactivity decay, an independent set of 26 GFR studies was evaluated. Counts obtained from all samples in these studies were higher than 10 000 and the exact time at which each sample was counted was recorded. GFR and V D were then calculated for each study, with and without decay correction. From this set of data the systematic, random and combined errors were computed.
Results
The scatter graphs of the uncorrected V D (L) and corrected V D (L) as a function of the BSA (m 2 ) are shown in figures 1 and 2 respectively with trendlines representing ± 2SD.
The correlation between V D (L), both uncorrected and corrected, and BSA (m 2 ) was significant (p < 0.001 for both correlations). Both were best described using linear functions:
(RMSE = 3.70 L; 95% CI for the coefficient: 9.79 to 10.5 L).
(RMSE = 2.53 L; 95% CI for the coefficient: 7.95 to 8.44 L).
In figure 1 There is overlap of the two lines representing -2SD. The association between T ½ (min) and age (years) was not statistically significant (p = 0.16), nor was the association between T ½ (min) and age (years) in subjects under the age of 40 years (p = 0.65). In this subgroup (< 40 years) the mean T ½ was 95.0 ± 36.2% (2SD). In subjects 40 years and older the association between T ½ and age was statistically significant (p = 0.046).
This bi-linear fit is illustrated in figure 3 . Using linear regression the following equation describes the association in subjects 40 years and older:
T ½ = [(0.49*age) + 75.9] min ± 30% (2SD)
The association between T ½ (min) and 1/BM-GFR Corr (min.(1.73m 2 ).ml -1 ) was statistically significant (p < 0.001) and it is illustrated in the scatter graph in figure 4 . Using linear regression it was best described using the equation: ]. This difference was statistically significant (p = 0.04), however, men were significantly younger than women, mean age 30.5 vs. 36.4 years (p = 0.003). Considering all 126 studies, the systematic and random errors (1SD) introduced to GFR data through statistical noise were -0.19% and 2.97% respectively, and for V D , 0.64% and 10.19%
respectively. In the prospective series of 26 studies the systematic and random errors (1SD) introduced to GFR data through not correcting for radioactivity decay were -0.12% and 1.81% respectively, and for V D , -0.22% and 2.37% respectively. In this series the counting of all samples was completed within 14 minutes (range 6 -14 min, mean 9 min).
Discussion
In this study reference ranges for a South African adult population were determined for V D , T ½ and GFR using 99m Tc-DTPA and the slope-intercept method as described in the BNMS Guidelines [2] . The slope-intercept method remains prone to methodological errors [5, 6] and various quality control checks have been proposed: the fit of the counts to a single exponential can be assessed, either graphically or by checking that the correlation coefficient is greater than 0.985 [2] . Alternatively, slope-intercept GFR measurements can be checked using singlesample estimates [27, 28] or using the slope-only technique [9, 14] . V D and T ½ are two quantities that are obtained during calculation of GFR using the slopeintercept method. The BNMS guidelines recommend reviewing these quantities as an additional quality control check [2] . For this purpose it is necessary to compare values to normal values for V D and T ½ defined for the patient population and for the radiopharmaceutical used.
In the present study a reference range for uncorrected V D in litres was identified as (10.1 * BSA) ± 40.6% (2SD). These values are systematically higher and show greater variability than those described in the BNMS guidelines (equation 1, fig. 1 ) [2] . Although the values for V D in the BNMS guidelines were derived from GFR measurements using 51 Cr-EDTA, previous studies demonstrated no significant difference in V D between 51 Cr-EDTA and 99m Tc-DTPA [21, 29] .
Therefore, it is believed that it is unlikely that the radiopharmaceutical justifies for the differences between the BNMS range and the values in the current study.
In this study the reference range for corrected V D in litres was found to be (8.19 * BSA) ± 34.4%
(2SD). The variability for corrected V D (34.4%) is noted to be lower than for uncorrected V D (40.6%). This is expected because uncorrected V D is overestimated relative to the true value and the degree of overestimation depends on GFR. Thus a subject of a given size will have a higher value for uncorrected V D if GFR is normal than if it is reduced. This GFR-related variability of V D is reduced by applying a Brochner-Mortensen correction.
In this study the values for corrected V D are systematically higher than those reported by University Hospital Southampton NHS Foundation Trust (equation 3, fig. 2 ) [13] . For example, for a BSA of 1.73 m 2 , the corrected V D using the Southampton equation would be 12.9 L whilst it would be 14.2 L using equation 11, leading to a 9% higher value. However, considering that the 2SD error for the Southampton data is 32% and for the data in the current study it is 34.4%, the difference in variability between the two centres is within the estimated error on the V D .
Radiopharmaceutical factors are even less likely to account for the differences in corrected V D between this centre and Southampton University Hospitals NHS Trust. In fact, both centres used TechneScan® DTPA, Covidien. This specifically excludes differences in protein binding of different DTPA preparations as a cause for the higher values or greater variability seen in V D .
The study populations in the two centres differ. The Southampton data was obtained from a general clinical GFR population, which included normal and abnormal GFRs and both children and adults, while the data in this study was obtained from a carefully selected normal adult population. This will affect the uncorrected values of V D . The overestimation of uncorrected V D will be higher in the normal group compared to the mixed population as the GFR will on average be higher. In terms of environmental and ethnic factors, the population in this study is likely to be more diverse than a population originating from Southampton. The current study population is heterogeneous, with roughly equal numbers of subjects of Caucasian, African and mixed ancestry. It has been shown in previous studies that there are differences in muscle mass amongst different ethnic groups and this may translate to differences in V D [30] [31] [32] .
An additional factor contributing to the variability in the results for V D might have been experimental error due to low counts; however, this is thought to play a minor role and it will be discussed later in this section. These values for ECV-BSA agree reasonably well with those described by Peters et al in their recent multi-centre UK-based study [16] .
The mean value for ECV in this study is 27% lower than the mean value for uncorrected V D . This is in close agreement with previous work in which a difference of 30% was described [33] .
The mean value for ECV-BSA in the current study is, however, also approximately 10% lower than the mean value for corrected V D normalized for BSA. This is due to the approximation used in this study that the slope of the second exponential is equal to the clearance constant. The work of Bird et al [15] shows that the slope systematically underestimates the constant by about 10% leading to an overestimate in the volume of distribution.
Calculation of T ½ may be used as a quality control check by comparing it against the value expected for the subject's GFR. The association between T ½ (min) and 1/BM-GFR Corr [min.(1.73m 2 ).ml -1 ] was statistically significant (p < 0.001) and T ½ (min) was found to be [9480*(1/BM-GFR Corr )] ± 35.1%.
In the study by Grewal and Blake, the authors noted that it was apparent that there was a break in the age dependence of GFR at approximately 40 years [20] . They found no statistically significant correlation between GFR and age for individuals under the age of 40 years, while there was a statistically significant decrease in GFR from the age of 40 years onward. In this study a cut-off of 40-years was used based on this work and it supports that conclusion: for individuals under the age of 40, the correlation between GFR and age was not statistically significant (p = 0.45), while it was significant (p < 0.001) in individuals 40 years and older. In individuals younger than 40 years the mean BM-GFR Corr was 108 ml.min . This is the same as the 108 ml.min -1 .(1.73m 2 ) -1 reported by Hamilton et al [19] , but higher than the 103 2 ) -1 found by Grewal and Blake [20] , but lower than the 98 ml.min -1 .(1.73m 2 ) -1 in the Granerus and Aurell study [18] . The data in the subgroup 40 years and older has to be interpreted with caution, however, as it comprised only 44 individuals and covered a relatively limited age range compared to the other studies.
The results of Granerus and Aurell [18] and Hamilton et al [19] are not directly comparable due to small differences in methodology. On the other hand, the current study is based on the protocol described in the BNMS guidelines [2] , as was the study by Grewal and Blake [20] , making it more appropriate for comparison.
It is accepted that GFR declines with age, although a cut-off age for the start of the decline is difficult to establish as recently shown by Peters et al [16] . No clear age cut-off could be identified in the current study, however a threshold of 40 years of age was chosen in accordance with the cut-off age used in a previous study [20] . Due to a relatively small study sample, individuals were not divided into groups based on gender, however, mean BM-GFR Corr was 107.0 ± 14.9 (1SD) ml.min -1 in women. The difference was statistically significant (p = 0.04), however, the difference might be explained by the fact that the male cohort was significantly younger than the female cohort (mean age 30.5 versus 36.4 years, p = 0.002). These mean values for GFR in men and women are higher than those described in the multi-centre UK study [16] , but this can be explained by two factors: firstly, the majority of GFR measurements (1783 of 1878) in the multi-centre study were performed using 51 Cr-EDTA and secondly, the mean age of subjects in all the individual centres was higher than the mean age of subjects in the current study. Due to the relatively small study population, individuals in the current study could not be sub-divided into groups based on other factors such as obesity as was done in the multi-centre study [16] .
In another study by the same authors the coefficient of variation (CV) of ECV-BSA in normal subjects was found to be useful in assessing departmental performance as it reflects the 'technical robustness' with which the department performs the GFR measurements [34] . The authors suggest a range of 10-20% as acceptable. The CV for ECV-BSA in this study (using the adult Brochner-Mortensen correction equation [8] ) was 15%.
The BNMS guidelines state that, where practical, a minimum of 10 000 counts should be obtained for each sample in order to reduce statistical errors [2] . In this study, 70 of the 126 GFR studies contained samples with fewer than 10 000 counts. The systematic error (1SD) in GFR and V D values due to counting error was found to be low (0.19% and 0.64% respectively).
As expected, the random error (1SD) was higher (GFR 2.97% and V D 10.19%). Another deviation from the BNMS guidelines was that no correction was made for the decay of Tc-99m.
The resultant systematic error (1SD) was negligible in all cases (GFR -0.12% and V D -0.22%) therefore it was ignored in further calculations. The random error (1SD) was larger (GFR 1.81% and V D 2.37%). By assuming that the error measured in the 26 cases represented the error introduced through not correcting for decay in all 126 studies, the combined random error of noise and lack of decay correction could be calculated. This resulted in 3.5% for GFR and 10.5% for V D (1SD).
The components of the relatively high combined random error in V D were assessed further. In 
The real standard deviation variation of uncorrected V D with BSA, y, is therefore 17.4%.
Similarly, for corrected V D , a 1SD error expressed as a percentage of the mean is 17.2% (equation 10) and the real standard deviation variation with BSA is 13.6%. These results show that, because the error in V D is relatively large, the contribution of low counts and lack of decay correction to this variability is small.
It is worth mentioning that a cohort of 126 studies is relatively small, therefore further larger studies are recommended to better define reference data for GFR using 99m Tc-DTPA. Secondly, the age of all individuals fell between 18 and 59 years, with few over the age of 50, as these were the subjects being considered as kidney donors. Ideally, a study of this nature should include subjects over a wider range of ages, including individuals over the age of 60 years as these are often the patients referred for GFR studies. Moreover, although the hospital's screening process for kidney donors is intensive, it may not have been rigorous enough to exclude all subjects with mild renal pathology.
Having defined the variation of volume of distribution with body surface area and its expected variation, this data may be used for quality control. Studies in which the value of V D lies outside the expected limits for the subject's BSA may be deemed fail the quality control (QC) test.
Considering the corrected V D data shown in Figure 2 , two of the studies lie well away from the 2SD limits and therefore may be considered to fail the QC requirements. Using 2SD limits, 5%
of the studies will lie outside the limits due to natural statistical variation, therefore in practical use wider limits might be used e.g. 2.5 or 3 SD. Several different methods of calculating volume of distribution exist and it is therefore important that in using this parameter in quality control values must be compared to the corresponding normal range for that particular estimation of the volume. A similar test may be applied to the measured T ½ . This is compared to the expected limits of T ½ for the subject's normalized GFR and if it lies outside these, then the study is deemed to fail the QC test (figure 4). One limitation of the current data in this respect is that it only contains data from control subjects. To obtain a better fit for low GFR further data is required.
Conclusion
This study has defined reference data for GFR, V D and T ½ from GFR studies using 99m Tc-DTPA in a healthy South African adult population. V D and T ½ values can provide useful quality control checks for GFR studies performed using the slope-intercept method as described in the BNMS guidelines [2] . Reference data for GFR will enhance the interpretation of adult 99m Tc-DTPA GFR measurements. The small difference in normal values for GFR in comparison to previous studies using 51 Cr-EDTA is in agreement with previous publications. represent ± 2SD (± 40.6%). The faint dotted lines represent the upper and lower limits of the reference range described in BNMS guidelines (8*BSA ± 25%) (2SD) [2] . There is overlap of the two lines representing -2SD. 
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